Method for increasing milk production by ruminants
This invention relates to the administration of an animal immunoglobulin source to mammals such as dairy cattle to improve milk production without negatively affecting reproductive parameters.
1. A method for increasing milk production in a ruminant comprising feeding the ruminant an effective amount of an immunoglobulin source derived from the blood plasma or blood serum of an animal.
2. A method for increasing milk production in a ruminant comprising feeding an effective amount of an immunoglobulin source to the ruminant comprising a mixture of dried animal plasma, dried animal serum and dried animal immunoglobulin concentrate.
3. A method according to claim 1 or 2 that provides an amount of said immunoglobulin source that is about to 0.1 wt-%-10 wt-% of the total mixed ration (TMR) of the ruminant.
4. The method of claim 3 wherein the amount is about 1 wt-%-5 wt-% of the total mixed ration (TMR) of the ruminant.
5. The method according claim 1 or 2 , wherein the ruminant is selected from the group consisting of a cow, sheep, goat, horse, yak, camel and llama.
6. The method of claim 5 wherein the ruminant is a cow.
7. The method according to claim 1 or 2 wherein said immunoglobulin source is derived from pigs, cattle, sheep, horses and poultry.
8. The method according to claim 1 or 2 that also increases milk fat content of the milk.
9. The method of claim 1 or 2 that maintains reproductive parameters in a cow, sheep, goat, horse, yak, camel or llama, wherein the reproductive parameter is selected from the group consisting of pregnancy rate and conception rate.
10. The method of claim 1 or 2 that maintains or improves body score condition in a cow, sheep, goat, horse, yak, camel or llama.
11. The method of claim 10 wherein the ruminant is a dairy cow.
12. The method of claim 1 or 2 whereby the immunoglobulin source is obtained in dried form from animal plasma or animal serum by spray-drying, freeze drying, ring drying or flash drying.
13. The method of claim 1 or 2 wherein the immunoglobulin source is administered in liquid form.